NPPA notified regarding the fixation of the retail price of Sitagliptin phosphate monohydrate IP eq. to Sitagliptin 100 mg + Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg + Metformin Hydrochloride IP 500 mg

Nov 26, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on November 25, 2024, notified regarding the fixation of the retail price of Sitagliptin phosphate monohydrate IP eq. to Sitagliptin 100 mg + Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg + Metformin Hydrochloride IP 500 mg.

The following has been stated namely: -

• It has fixed the rate at Rs. 14.15/- for the Composition of each coated bilayered tablet containing: Sitagliptin phosphate monohydrate IP eq. to Sitagliptin 100 mg + Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg + Metformin Hydrochloride IP (As sustained release form) 500 mg.

[Notification no. - 19(4282)/2024/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT